In patients with sporadic colorectal cancer, the tumor suppressor adenomatous polyposis coli (APC) gene is mutated early to activate the canonical Wnt/β-catenin signaling pathway, whereas in patients with colitis-associated colon cancer, APC mutations occur late in cancer progression [127]. The gene discussed is APC; the disease is colitis.